Sir, we recently surveyed GDPs\' understanding of the oral management of patients at risk of developing osteoradionecrosis of the jaw (ORN), a serious complication following radiotherapy for head and neck cancer treatment. The other oral impacts include, but are not limited to, xerostomia, mucositis, and trismus, which increase the patient\'s susceptibility to dental caries and periodontal disease. They are therefore at higher risk of needing non-surgical and surgical dental treatment that could result in the increased risk of developing ORN. GDPs have a key role in the prevention and identification of ORN and it is imperative that we have a thorough understanding of the condition and the oral health management for these patients. In the current COVID-19 climate, many patients diagnosed with oral and pharyngeal cancers have been directed away from surgical treatment and therefore there has been an increase in the number of patients undergoing head and neck radiotherapy.

The survey we designed included questions that investigated GDPs\' understanding and confidence levels surrounding ORN. They explored which prevention and treatment strategies, guideline recommendations and factors that GDPs would consider when referring a patient at risk of developing ORN to specialist care. A total of 121 GDPs, who graduated over a wide range of years, completed the survey.

The results indicated that approximately a third of GDPs did not feel confident recognising a potential case of ORN that would require a specialist referral, with some stating lack of experience in recognising the condition as the reason why. Factors affecting GDPs\' decisions to refer extractions to a specialist included the number and nature of the extractions and patient comorbidities including previous radiotherapy to the head and neck. Notably, 50% of GDPs stated concerns over litigation in the event of development of ORN as a factor that would influence referral. The results also revealed a range of confidence levels in providing routine dentistry in patients with a history of head and neck radiotherapy.

Improving survival rates mean many more GDPs will be managing the long-term oral healthcare of head and neck cancer survivors. Their confidence and ability to manage the oral sequelae of radiotherapy is essential. We feel that the results highlight how further education and continued professional development surrounding ORN for GDPs is required. We would also like to draw attention to the current guidelines and recommendations by The Royal College of Surgeons of England and the British Society for Disability and Oral Health which focuses on the oral management of oncology patients.^[@CR7650]^
